The Anemia Panel 2 Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify and evaluate various forms of anemia. Priced at 970 AED, this test is an essential resource for individuals experiencing symptoms such as fatigue, weakness, pale skin, and other signs indicative of anemia. The panel encompasses a series of blood tests that measure levels of hemoglobin, hematocrit, and different types of blood cells, among other parameters, to pinpoint the specific type and cause of anemia. This information is crucial for determining the most effective treatment plan. Conducted in the state-of-the-art facilities of DNA Labs UAE, the Anemia Panel 2 Test ensures accurate and reliable results, empowering patients with the knowledge needed to address their condition effectively.
The "Immunohistochemistry Breast Cancer Panel 2 Test," available at DNA Labs UAE for 960 AED, is a specialized diagnostic tool used in the evaluation and management of breast cancer. This test employs immunohistochemistry (IHC) techniques to detect the presence and quantify the expression levels of specific protein markers in breast tissue samples. These markers are crucial for understanding the biological behavior of the cancer, predicting its aggressiveness, and determining the most effective treatment strategies.
By targeting a panel of biomarkers specifically chosen for their relevance in breast cancer, the test provides comprehensive insights into the tumor's characteristics. This information is invaluable for tailoring treatment plans to the individual patient, potentially improving outcomes by selecting therapies that are more likely to be effective based on the tumor's profile.
DNA Labs UAE, known for its commitment to precision and accuracy in diagnostic services, offers this test at a cost of 960 AED. The facility ensures that the testing process, from sample collection to analysis and reporting, is conducted according to the highest standards of quality and reliability. This test is an essential component of modern breast cancer care, facilitating a more personalized approach to treatment and management of the disease.
The Reticulin IgA Antibody Test is a specialized diagnostic procedure aimed at detecting the presence of reticulin antibodies in the blood. These antibodies are a type of immunoglobulin A (IgA) that target reticulin, a protein found in the connective tissue of the body. The presence of these antibodies is often associated with autoimmune conditions, such as celiac disease, wherein the body's immune system mistakenly attacks its own tissues.
This test is particularly useful for healthcare providers in diagnosing and managing conditions related to immune system dysfunction. It involves collecting a blood sample from the patient, which is then analyzed for the presence of reticulin IgA antibodies. The results can provide valuable information regarding the patient's immune response and help in the formulation of an appropriate treatment plan.
In the UAE, the Reticulin IgA Antibody Test is available at DNA Labs, a leading laboratory known for its advanced diagnostic services and state-of-the-art facilities. The cost of the test is 960 AED, which reflects the comprehensive analysis and accuracy provided by DNA Labs. Patients seeking this test can expect professional service and reliable results that contribute to their healthcare management.
The FISH - BCR ABL or Philadelphia Translocation Test is a specialized diagnostic procedure designed to identify the presence of the Philadelphia chromosome or BCR-ABL gene fusion in blood or bone marrow samples. This genetic abnormality is a hallmark of chronic myeloid leukemia (CML) and some types of acute lymphoblastic leukemia (ALL), making this test crucial for accurate diagnosis and tailored treatment planning.
Fluorescence in situ hybridization (FISH) technology is utilized in this test to detect the specific genetic translocation between chromosomes 9 and 22, which results in the creation of the Philadelphia chromosome. The presence of this chromosome leads to the production of an abnormal tyrosine kinase protein that promotes uncontrolled cell division, a key feature of leukemia.
Offered by DNA Labs UAE, the test is conducted in a state-of-the-art laboratory setting by skilled professionals. With a cost of 960 AED, patients are provided with a reliable, precise, and timely analysis of their genetic status regarding the BCR-ABL fusion gene. This information is vital for oncologists to determine the most effective treatment approach, including targeted therapy options that specifically inhibit the activity of the BCR-ABL protein, thereby offering a better prognosis for patients with CML and certain types of ALL.
The ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test is a cutting-edge diagnostic procedure designed to evaluate an individual's genetic predisposition towards the efficacy of beta-2 agonist medications. This test specifically targets the ADRB2 gene, which encodes the beta-2 adrenergic receptor. Variations in this gene can significantly influence an individual's response to beta-2 agonists, a class of drugs commonly used in the treatment of asthma and other respiratory conditions. By analyzing the genetic makeup of the ADRB2 gene, healthcare providers can tailor medication plans to better suit the genetic profile of their patients, potentially enhancing drug efficacy and minimizing side effects.
Performed at DNA Labs UAE, a leading facility in genetic testing, the ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test is priced at 960 AED. The lab utilizes state-of-the-art technology to ensure accurate and reliable results, providing valuable insights into personalized medicine. This test represents a significant step forward in the field of pharmacogenomics, offering a more individualized approach to the management of respiratory conditions.
The Hyperthyroid Graves' Disease Panel Test is a comprehensive diagnostic tool used to evaluate and diagnose Graves' disease, an autoimmune disorder that is the most common cause of hyperthyroidism. This condition occurs when the immune system mistakenly attacks the thyroid gland, leading to an overproduction of thyroid hormones. These hormones are crucial for regulating the body's metabolic rate, and their excess can lead to a wide range of symptoms including weight loss, rapid heartbeat, sweating, and anxiety.
DNA Labs UAE offers this specialized panel test at a cost of 950 AED. The panel typically includes a series of blood tests designed to measure the levels of thyroid-stimulating hormone (TSH), Free T4, Free T3, and the presence of thyroid-stimulating immunoglobulins (TSI) that can indicate Graves' disease. The test may also check for the presence of other antibodies that could suggest a different autoimmune thyroid condition.
Conducted in a state-of-the-art facility, the Hyperthyroid Graves' Disease Panel Test at DNA Labs UAE is designed to provide accurate and comprehensive results. These results can help healthcare providers develop an effective treatment plan tailored to the individual's condition. Early detection and treatment of Graves' disease are crucial for managing symptoms and preventing complications, making this test an important tool for those experiencing symptoms of hyperthyroidism.
The IGF Binding Protein - 3 (IGFBP-3) test is a specialized blood test that measures the level of IGFBP-3 in the bloodstream. IGFBP-3 is one of the most important proteins that bind insulin-like growth factors (IGFs), which play a crucial role in regulating growth, development, and metabolism. The concentration of IGFBP-3 in the blood can provide valuable insights into an individual's growth hormone (GH) activity, since it reflects the amount of GH indirectly. This test is particularly useful in evaluating children and adults with growth disorders, assessing GH deficiency or excess, and monitoring treatment efficacy in growth hormone therapies.
At DNA Labs UAE, the IGFBP-3 test is offered for a cost of 950 AED. The laboratory is equipped with state-of-the-art technology to ensure accurate and reliable test results. Patients opting for this test at DNA Labs UAE can expect professional service and comprehensive support throughout the testing process, from sample collection to result interpretation.
The Sphingolipidosis Panel 2 Test is a specialized genetic test offered by DNA Labs UAE, designed to diagnose various types of sphingolipidoses, a group of inherited metabolic disorders characterized by the accumulation of harmful sphingolipids in the body's cells. These disorders can affect many body systems, including the nervous system, leading to a range of health issues. The test, priced at 950 AED, involves analyzing specific genes associated with different forms of sphingolipidoses to identify mutations that may cause these conditions. By providing a precise genetic diagnosis, the Sphingolipidosis Panel 2 Test enables targeted treatment approaches, helping to manage symptoms and improve the quality of life for affected individuals. Conducted at DNA Labs UAE, this test represents a crucial step for families seeking answers about sphingolipidosis-related health concerns, offering them access to cutting-edge genetic insights and care.
The "Histopathology Kidney Biopsy Panel 1 Test" is a diagnostic examination conducted at DNA Labs UAE, aimed at analyzing kidney tissue for signs of disease or damage. This test is crucial for diagnosing various kidney conditions, including infections, autoimmune diseases, and cancer. It involves obtaining a small sample of kidney tissue through a biopsy procedure, which is then examined under a microscope by a pathologist. The detailed analysis helps in identifying the type, extent, and cause of kidney damage, facilitating targeted treatment plans. Priced at 950 AED, this test is a valuable tool in the management and diagnosis of kidney-related disorders, providing patients with accurate and timely results.
The 5-Aminolevulinic Acid (5-ALA) 24-Hour Urine Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to measure the levels of 5-Aminolevulinic Acid in the urine collected over a 24-hour period. 5-ALA is a crucial compound in the body, serving as a precursor in the biosynthesis of heme, the iron-containing component of hemoglobin. Abnormal levels of 5-ALA can indicate a variety of conditions, most notably acute intermittent porphyria, a rare metabolic disorder affecting the production of heme. The test is priced at 940 AED and offers valuable insights into the patient's metabolic state, aiding in the diagnosis and management of conditions related to heme synthesis. By collecting urine over 24 hours, this test ensures a comprehensive overview of the body's 5-ALA levels, providing a reliable basis for medical assessment and intervention.
